On April 30, 2026, the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list entirely, citing no clinical need for large-scale compounding now that FDA-approved supply is stable
10.1016/j.plantsci.2013.03.017 Plant Sci
Common lipotropic ingredients include methionine, inositol, choline, and vitamin B12
Oral supplements like tablets or capsules of vitamin C, glutathione, or multivitamins pass through the digestive system, where your body may not absorb them well
10.1016/j.biochi.2021.10.017 47 MartinsF